Berg et al., 1972 - Google Patents
Recovery of Australia antigen from human plasma products separated by a modified Cohn fractionationBerg et al., 1972
- Document ID
- 9489295509914801907
- Author
- Berg R
- Björling H
- Berntsen K
- Espmark
- Publication year
- Publication venue
- Vox Sanguinis
External Links
Snippet
One liter of strongly Australia antigen positive plasma was subjected to a modified Cohn fractionation and samples from the various steps of the process were assayed quantitatively for Australia antigen. More than 85% of the original quantity of Australia antigen was …
- 239000000427 antigen 0 title abstract description 68
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2155630C (en) | Low temperature albumin fractionation using sodium caprylate as a partitioning agent | |
| Handin et al. | Antibody-induced von Willebrand's disease: a newly defined inhibitor syndrome | |
| Leikola et al. | IgA-induced anaphylactic transfusion reactions: a report of four cases | |
| US5122373A (en) | Immunoglobulin-g-containing fraction | |
| AU631471B2 (en) | A method for isolating factor viii | |
| Björling | I. Plasma fractionation methods used in Sweden | |
| Berg et al. | Recovery of Australia antigen from human plasma products separated by a modified Cohn fractionation | |
| CA1061251A (en) | Method of removing hepatitis-associated antigen from protein fraction | |
| Todd et al. | Comparison of the allotypic combining sites on H-chains of rabbit IgG and IgM | |
| US4762714A (en) | Preparation of retrovirus-free immunoglobulins | |
| Bing et al. | Purification of Subcomponents Clq, Cl [rbar] and Cl [sbar] of the First Component of Complement from Cohn Fraction I by Affinity Chromatography | |
| SG193738A1 (en) | Process for obtaining an igg composition through heat treatment | |
| Hughes-Jones et al. | The Kell system studied with radioactively-labelled anti-K | |
| Koutts et al. | Immunological evidence that human factor VIII is composed of two linked moieties | |
| Vargas et al. | Human plasma‐derived immunoglobulin G fractionated by an aqueous two‐phase system, caprylic acid precipitation, and membrane chromatography has a high purity level and is free of detectable in vitro thrombogenic activity | |
| Hao | A simple method for the preparation of human serum albumin | |
| Wickerhauser et al. | Development of Large‐Scale Fractionation Methods: VI. An Improved Method for Preparation of Antihemophilic Factor 1 | |
| Barrowcliffe et al. | Small scale preparation and clinical use of factor IX‐prothrombin complex | |
| Mulford et al. | Preparation of a stable human plasma protein solution | |
| Koutts et al. | The dynamic inter-relationship between factor VIII and von Willebrand factor | |
| Leveque et al. | HBs antigen in human plasma fractions | |
| Pasqua et al. | The role of ligand-ligand interactions in competition by fibrinogen and fibrin degradation products for fibrinogen binding to human platelets | |
| Branović et al. | Characterization of F VIII concentrates produced by two methods incorporating double virus inactivation | |
| Howard et al. | Further studies on the factor VIII of a patient with a variant form of von Willebrand's disease | |
| EP0049161B1 (en) | Method for preparing sample for use in endotoxin test and kit for preparing said sample |